D-1036-2016 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-1036-2016 was initiated by Sandoz Inc on May 25, 2016 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert The recall status is terminated (terminated Apr 25, 2017). Affected quantity: 3,048 bottles ( 304,800 tablets).

Recall details

Product Type
Drugs
Report Date
Jun 22, 2016
Initiation Date
May 25, 2016
Termination Date
Apr 25, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,048 bottles ( 304,800 tablets)

Product description

Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0185-0630-01

Reason for recall

Labeling: Incorrect or Missing Package Insert

Distribution pattern

Nationwide

Code information

Lot # FC1960; Exp.: 02/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1036-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1036-2016. Report a data issue: hello@regdatalab.com.